LeadArtis is pleased to announce its participation as coordinator of the ATTACK project (Cancer...
Corporate Headquarters
C/ Ferraz 78- 2º Izqda
28008 Madrid
40.425846x-3.717027:16
Latest News
|
Leadartis discloses the project: ATTACK-Cancer immunotherapy by bispecific antibodies that recruit T lymphocytes
11-12-2018
|
Medical oncologist Dr. Luis Paz-Ares MD, Ph.D joins Leadartis´ scientific advisory board
10-12-2018
Luis Paz-Ares MD, PhD. Chair of the Medical Oncology Department at the Hospital 12 de Octubre,... |
Nature Communications: LeadArtis outlines a new bispecific antibody that could hold the key to activate cancer killer T-cells to find and destroy highly prevalent tumors
17-11-2018
LeadArtis and collaborators have published in the highly regarded scientific journal Nature... |
